UK health regulator may restrict AstraZeneca shot for younger people, Channel 4 says



© Reuters. FILE PHOTO: COVID-19 vaccination at Newmarket Racecourse

LONDON (Reuters) – Britain’s health regulator is considering a proposal to restrict the use of the Oxford-AstraZeneca vaccine in younger people over concerns about very rare blood clots, Channel 4 News reported on Monday.

“Two senior sources have told this programme that while the data is still unclear there are growing arguments to justify offering younger people – below the age of 30 at the very least – a different vaccine,” the broadcaster reported.

The UK’s regulator, the MHRA, has previously said the benefits of the vaccine in the prevention of COVID-19 far outweigh any possible risk of blood clots.

The MHRA did not immediately respond to a comment on the Channel 4 report.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

READ  UK variant linked to high viral loads, Neanderthal gene offers protection





READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here